PURCHASE, N.Y., Oct. 31 /PRNewswire-FirstCall/ -- Nutrition 21, Inc. (Nasdaq: NXXI), a developer and marketer of nutritional supplements that help consumers manage blood sugar levels, improve cardiovascular health, enhance memory and address chronic joint pain, will report preliminary financial results -- prior to the opening of the market -- on Thursday, November 13, 2008 for the first quarter of fiscal year 2009, ended September 30, 2008. The Company has scheduled a conference call to review the results later that morning, Thursday, November 13, 2008 at 10:00AM ET.
Participants can dial (866) 562-9910 or (706) 679-5064 to access the conference call, or can listen via a live Internet web cast, which can be found at http://www.nutrition21.com. A replay of the call will be available by visiting http://www.nutrition21.com for 30 days or by calling (800) 642-1687 or (706) 645-9291, access code 69805873, through November 16, 2008.
About Nutrition 21
Nutrition 21, Inc., headquartered in Purchase, NY, is a nutritional
bioscience company and the maker of chromium picolinate-based and omega-3
fish oil-based supplements with health benefits substantiated by clinical
research. Nutrition 21 holds more than 30 patents for nutrition products
and uses. Nutrition 21's portfolio of health and wellness brands include:
Chromax(R), Iceland Health Advanced Memory Formula(TM), Diabetes
Essentials(R), Iceland Health(R) Maximum Strength Omega-3 and Iceland
Health(R) Joint Relief. The company also manufactures private label
supplements and ingredients for third parties. Nutrition 21 products are
sold nationally through more than 29,0
'/>"/>
| SOURCE Nutrition 21, Inc. Copyright©2008 PR Newswire. All rights reserved |